1. Home
  2. ACON vs NVNO Comparison

ACON vs NVNO Comparison

Compare ACON & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclarion Inc.

ACON

Aclarion Inc.

N/A

Current Price

$1.99

Market Cap

6.6M

Sector

Technology

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$7.31

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACON
NVNO
Founded
2008
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.1M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
ACON
NVNO
Price
$1.99
$7.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 34.7K
32.1K
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.82
N/A
EPS
★ N/A
N/A
Revenue
★ $75,730.00
$31,243.00
Revenue This Year
$44.55
N/A
Revenue Next Year
$123.97
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 65.62
N/A
52 Week Low
$1.85
$0.30
52 Week High
$9.36
$13.44

Technical Indicators

Market Signals
Indicator
ACON
NVNO
Relative Strength Index (RSI) 34.87 33.53
Support Level N/A $0.31
Resistance Level $3.54 $11.47
Average True Range (ATR) 0.10 0.80
MACD -0.03 -0.02
Stochastic Oscillator 15.18 12.74

Price Performance

Historical Comparison
ACON
NVNO

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: